The lower fee comes as big device makers lobbied hard against the proposed $40 million fee, enlisting senators in their home states of Minnesota, California, Massachusetts and elsewhere.
The original reform bills in the U.S. House did not have a device fee, but House Democrats are now devising an excise tax on medical devices, to be paid at the point of sale, that would yield a total of $20 billion between 2013 and 2019.
Read the Wall Street Journal’s report on the proposed medical device fee.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
